Dipeptidyl peptidase IV (DPPIV/CD26) inhibition does not improve engraftment of unfractionated syngeneic or allogeneic bone marrow after nonmyeloablative conditioning

In order to develop minimally toxic bone marrow transplantation (BMT) protocols suitable for use in a wider range of indications, it is important to identify ways to enhance BM engraftment at a given level of recipient conditioning. CXCL12/stromal cell-derived factor-1α plays a crucial physiological...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Schwaiger, Elisabeth, Klaus, Christoph, Matheeussen, Veerle, Baranyi, Ulrike, Pilat, Nina, Ramsey, Haley, Korom, Stephan, De Meester, Ingrid, Wekerle, Thomas
Natura: Artigo
Lingua:Inglês
Pubblicazione: Elsevier Science Inc 2012
Soggetti:
Experimental Stem Cell Transplantation
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3265670/
https://ncbi.nlm.nih.gov/pubmed/22085453
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.exphem.2011.10.010
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi